FREE Daily Stock Alerts From Stock-PR.com
GreenHouse Holdings, Inc. (Pinksheets:GRHU) a leading provider of energy efficiency solutions and sustainable infrastructure products, just recently announced that it has been engaged to implement Southern California Edison's (SCE) Automated Demand Response (Auto-DR) program for two industrial customers. The customers include Apogee Containers, Inc. and MGE UPS, LLC.
GreenHouse estimates that the projects will generate $400,000 in revenue for GreenHouse, based upon approximately 1,300 kW or 1.3 MW of electricity demand reduction and infrastructure improvements from the engagements. GreenHouse is a qualified service provider of SCE's Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies including complete processing of all utility documents.
"Auto-DR is just one of the innovative services Greenhouse offers to help our clients implement cost effective solutions that produce positive results for all parties involved," remarked Russ Earnshaw, President of GreenHouse. "We are truly honored to be selected by Apogee and MGE UPS and we anticipate Auto-DR being the first of many services offered in support of their energy stewardship initiatives."
“Auto-DR is just one of the innovative services Greenhouse offers to help our clients reduce energy consumption by deploying state-of-the-art technology,” says Rob Davis, Vice President of GreenHouse Holdings, Inc. “We are truly honored to be selected by Gulfstream and we are looking forward to the Auto-DR project as the first of many services offered in support of Gulfstream’s corporate energy stewardship initiatives. This project goes to the heart of Greenhouse’s mission to deliver sustainable solutions that reduce energy consumption with a positive return on investment.”
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3’s depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.
“We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now,” stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. “We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.”
Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.
Parkinson’s disease is really a disorder that influences neurological cells, or neurons, found in the portion of the brain in which deals with muscle movement. In Parkinson’s, neurons that make an important chemical substance known as dopamine die or do not work properly. Dopamine generally delivers impulses that will help coordinate an individual’s movements. Nobody has found out whatever injuries these kind of cells perform. As signs and symptoms get worse, people with Parkinson’s disease could possibly have trouble walking, talking or doing simple tasks. They may also have problems such as depression, sleep problems or trouble chewing, swallowing or speaking.
International, breast cancer consists of 10.4% in all cancer incidence among the ladies, defining it as the most common method of non-skin cancer in females and then the 5th most typical reason for cancer death. In 04, cancer of the breast induced 519,000 fatalities globally (7% connected with cancer deaths; practically 1% of all deaths). Breast cancers is about one hundred times more widespread in women than in men, even though men generally have poorer success on account of delays in medical diagnosis.
Alzheimer’s illness (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia of an Alzheimer’s type (PDDAT), or Alzheimer’s-is often the most common type of dementia. This particular incurable, degenerative, and deadly condition was initially described by German psychiatrist and even neuropathologist Alois Alzheimer in 1906 and even was named after him. Most often, it really is diagnosed in people more than 65 years of age, but the less-prevalent early-onset Alzheimer’s may appear much earlier. In 2006, there were 26.6 million individuals around the world. Alzheimer’s is usually expected to influence 1 in 85 people today worldwide by the year 2050.
Janus Capital Group Inc. (NYSE:JNS) issued the following statement on behalf of Dick Weil, CEO of Janus, following the announcement from S&P that it has upgraded the company’s credit rating to BBB- from BB+, with a stable outlook. “We’re pleased that S&P recognizes the progress we’ve made in significantly deleveraging the firm’s balance sheet and creating a strong capital structure. Most importantly, Janus’ investment grade ratings from S&P and Moody’s reflect the firm’s commitment to being a stable and trusted partner to our clients through the expected volatility of a full-market cycle.
Janus Capital Group, Inc. is a publicly owned asset management holding company with approximately $167.7 billion in assets under management. It also provides retirement planning, investment planning, tax planning, investment for college, and tax planning services to its clients.
Tri-Continental Corporation (NYSE:TY) announced that it will hold its 81st Annual Meeting of Stockholders on April 14, 2011 (the “Meeting”) in Minneapolis, MN. The close of business on February 16, 2011 has been fixed by the Corporation’s Board of Directors as the record date for the determination of Stockholders entitled to notice of, and to vote at, the Meeting or any postponement or adjournment thereof. At the Meeting, Stockholders will be asked to elect three directors, each to hold office until the 2014 Annual Meeting of Stockholders and all until their successors are elected and qualify, to consider the ratification of the Board’s selection of Ernst & Young LLP as the Corporation’s independent registered public accounting firm, to consider a proposal to amend the Corporation’s policy on securities lending, and to consider such other matters as may properly come before the Meeting or any postponement or adjournment thereof.
Tri-Continental Corporation is a closed-ended equity mutual fund launched and managed by Columbia Management Investment Advisers, LLC. It primarily invests in the public equity markets of the United States.
Penn Virginia Corp. (NYSE:PVA) announced that it will release its fourth quarter and full-year 2010 financial results after the market closes on Wednesday, February 23, 2011 and hold a conference call / webcast on Thursday, February 24, 2011 at 10:00 a.m. ET. We invite you to listen to the conference call, during which prepared remarks by A. James Dearlove, President and Chief Executive Officer, and other members of management will be followed by a question and answer session. You can participate in the conference call by phone or via the Internet. Conference call to discuss fourth quarter and full-year 2010 results Timing: February 24, 2011 at 10:00 a.m. ET. Internet: Log onto PVA’s website, www.pennvirginia.com.
Penn Virginia Corporation engages in the development, exploration, and production of natural gas and oil in east Texas, the Mid-Continent, Appalachia, and Mississippi regions of the United States.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (OTCQB:GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.